FDA Inspection 1073444 — Genus Lifesciences Inc.
The FDA completed an inspection of Genus Lifesciences Inc. on Nov 28, 2018 in Allentown, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 28, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Allentown, PA (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)